[HTML][HTML] Role of hypoxia-inducible factor-1α as a cancer therapy target
S Patiar, AL Harris - Endocrine-related cancer, 2006 - erc.bioscientifica.com
Hypoxia occurs in solid tumours due to a mismatch between tumour growth and
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …
Role of hypoxia-inducible factor-1α as a cancer therapy target
S Patiar, AL Harris - Endocrine-Related Cancer, 2006 - cir.nii.ac.jp
抄録< jats: p> Hypoxia occurs in solid tumours due to a mismatch between tumour growth
and angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype …
and angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype …
Role of hypoxia-inducible factor-1alpha as a cancer therapy target
S Patiar, AL Harris - Endocrine-related cancer, 2006 - pubmed.ncbi.nlm.nih.gov
Hypoxia occurs in solid tumours due to a mismatch between tumour growth and
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …
Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
S Patiar, AL Harris - Endocrine-related Cancer, 2006 - europepmc.org
Hypoxia occurs in solid tumours due to a mismatch between tumour growth and
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …
angiogenesis. Hypoxia in solid tumours is associated with an aggressive phenotype and …